Search
for
Sort by
Research 91–120 of 1000+
- Chromium supplementation in women with polycystic ovary syndrome: Systematic review and meta-analysis
- Salivary Testosterone in Hirsutism: Correlations with Serum Testosterone and the Degree of Hair Growth
- Global Adiposity and Thickness of Intraperitoneal and Mesenteric Adipose Tissue Depots Are Increased in Women With Polycystic Ovary Syndrome (PCOS)
- Cardiometabolic profile of young women with hypoprolactinemia
- Effects of Low-Dose Spironolactone Combined with Metformin or Either Drug Alone on Insulin Resistance in Patients with Polycystic Ovary Syndrome: A Pilot Study
- Correlation between Hormonal Imbalances and Adult Female Acne
- CORRELATION OF CUTANEOUS MANIFESTATIONS WITH HORMONAL PROFILE IN WOMEN WITH POLYCYSTIC OVARY SYNDROME
- Early onset androgenic alopecia: not a cosmetic problem but a sign of life time risk factors. Male phenotypic equivalent of polycystic ovarian syndrome: Is There a Male Phenotype of PCOS
- Free androgen index (FAI)’s relations with oxidative stress and insulin resistance in polycystic ovary syndrome
- Effect of Testosterone Supplementation With and Without a Dual 5α-Reductase Inhibitor on Fat-Free Mass in Men With Suppressed Testosterone Production
- Salivary Inflammatory Markers and Free Androgen Index in Women with Polycystic Ovary Syndrome: A Case-Control Study
- Elevated Free Testosterone Levels in Women With Acne
- Correlation of clinical profile and anthropometry factors with free androgen index in evaluation of polycystic ovarian syndrome
- Serum Preptin and Amylin Levels with Respect to Body Mass Index in Polycystic Ovary Syndrome Patients
- In vivo and in vitro exposure to free fatty acids induce increased androgen production in animal models: a potential pathogenic factor of the polycystic ovary syndrome
- Protective role of agomelatine via modulation of TLR4/NF-κB: NLRP3/IL-1β signaling pathways in testosterone-induced benign prostatic hyperplasia in rats
- The value of the free androgen index depends on the phenotype of polycystic ovary syndrome — a single-centre experience
- Pharmacokinetics of a transdermal testosterone cream in healthy postmenopausal women
- Effects of depot medroxyprogesterone acetate, the copper IUD and the levonorgestrel implant on testosterone, sex hormone binding globulin and free testosterone levels: ancillary study of the ECHO randomized clinical trial
- The Optimal Indication for Testosterone Replacement Therapy in Late Onset Hypogonadism
- Vitamin B<sub>3</sub> (niacin), B<sub>6</sub>, C, and iron intake are associated with the free androgen index, especially in normoandrogenic polycystic ovary syndrome
- Pharmacokinetics of Modified Slow-Release Oral Testosterone Over 9 Days in Normal Men With Experimental Hypogonadism
- Free Testosterone Levels in Patients with Covid-19 and its Association with Disease Severity
- PLASMA TESTOSTERONE GLUCOSIDURONATE: A RELIABLE INDICATOR OF FEMALE HYPERANDROGENISM (IDIOPATHIC HIRSUTISM AND ANDROGENIC ALOPECIA)
- Cutaneous Findings and Systemic Associations in Women With Polycystic Ovary Syndrome
- Testosterone, Dihydrotestosterone, and Incident Cardiovascular Disease and Mortality in the Cardiovascular Health Study
- Sexual Function and Depressive Symptoms in Young Women With Nonclassic Congenital Adrenal Hyperplasia
- Factors associated with risk for depression among women with polycystic ovarian syndrome
- P131 Menstrual irregularity in hirsute women
- Nutritional Assessment of Selected Emerging Adult Women with Poly Cystic Ovarian Syndrome